FDA Adverse Event Malfunction Summary report: N

INSET GUARD

MDR report key: 24701264 · Received March 26, 2026

Report

Report Number
8021545-2026-99918
Event Type
Malfunction
Date Received
March 26, 2026
Date of Event
October 30, 2023
Report Date
February 25, 2026
Manufacturer
UNOMEDICAL A/S
Product Code
FPA
UDI-DI
05705244023079
PMA / PMN Number
K210544
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

E1: PATIENT CITY: (B)(6). PATIENT COUNTRY: UNITED STATES. UNOMEDICAL HEREBY SUBMITS THIS INITIAL REPORT AS PART OF ITS COMPLAINT REMEDIATION ACTIVITIES CONDUCTED UNDER A CORRECTIVE AND PREVENTIVE ACTION (CAPA)/FDA ACTION PLAN. THIS SUBMISSION INCLUDES A RETROSPECTIVE REASSESSMENT OF PREVIOUSLY EVALUATED COMPLAINTS. UNOMEDICAL IS PROVIDING THIS INITIAL INFORMATION IN ACCORDANCE WITH THE REPORTING REQUIREMENTS SET FORTH IN 21 CFR PART 803. ANY FIELDS LEFT BLANK INDICATE THAT THE INFORMATION IS UNKNOWN, UNAVAILABLE, OR REMAINS UNCHANGED. BASED ON THE REVIEW COMPLETED ON 25-FEB-2026 AND INVESTIGATION COMPLETED ON 13-MAR-2026 THIS MEDICAL DEVICE REPORT (MDR) IS BEING SUBMITTED AS THE INITIAL REPORT. ADDITIONAL INFORMATION - THIS MDR IS BEING SUBMITTED TO INCLUDE THE BELOW: H6: INVESTIGATION RESULTS UNDER TYPE OF INVESTIGATION, INVESTIGATION FINDINGS, INVESTIGATION CONCLUSIONS. H11: INVESTIGATION SUMMARY. COMPLAINT INVESTIGATION RESULTS: REVIEW OF COMPLAINT RECORD (B)(4) EVENT DESCRIPTION AND ALL AVAILABLE INFORMATION WAS COMPLETED, AND LOT NUMBER: 6002062 WAS PROVIDED. COMPLAINT WAS CLASSIFIED UNDER MALFUNCTION CODE: INFUSION SITE EGRESS- TRACE MOISTURE / SUPERFICIAL WETNESS. A QUERY WAS RUN IN THE ELECTRONIC QUALITY MANAGEMENT SYSTEM (EQMS) ON 13-MAR-2026 AGAINST "LOT NUMBER" "6002062" AND SIMILAR MALFUNCTION CODE(S). INFUSION SITE EGRESS- TRACE MOISTURE / SUPERFICIAL WETNESS. INFUSION SITE LEAKAGE - TRACE MOISTURE / SUPERFICIAL WETNESS. INFUSION SITE LEAKAGE - TRACE MOISTURE / SUPERFICIAL WETNESS. LEAKAGE INFUSION SITE (CANNULA BASE PART/CANNULA) (SPECIFIC CAUSE NOT IDENTIFIED). LEAKAGE FROM INFUSION SITE (CANNULA BASE PART/CANNULA) (SPECIFIC CAUSE NOT IDENTIFIED). NO RECORDS WERE IDENTIFIED FOR THIS LOT AND SIMILAR RELATED ISSUES. A NON CONFORMANCE(NC)/CAPA QUERY SEARCH WAS RUN IN THE EQMS SYSTEM PERFORMED ON 13-MAR-2026 AGAINST "LOT/BATCH NUMBER" "6002062". NO RECORDS WERE FOUND. DHR REVIEW: THE DEVICE HISTORY RECORD (DHR) FOR LOT: 6002062 WAS REVIEWED. REVIEW OF THE DHR SHOWED THAT ALL RELEVANT TESTS REQUIRED DURING THE RELATED PROCESSES HAD BEEN FULFILLED AND MET THE REQUIREMENTS. NO DEVIATION WAS IDENTIFIED, NOR MAINTENANCE EVENTS WERE RECORDED RELATED TO COMPLAINT CODE . CONCLUSION OF COMPLAINT INVESTIGATION: LOT NO. 6002062 WAS PROVIDED, HOWEVER, AS THE COMPLAINT IS CATEGORIZED AS A REPORTABLE WITH NO HARM REPORTED AND NO ISSUES WERE FOUND DURING EQMS SEARCH AND DHR REVIEW: NO VISUAL INSPECTION IS REQUIRED TO BE PERFORMED. NO RETAIN SAMPLE TESTING IS REQUIRED TO BE CONDUCTED. NO FURTHER ASSESSMENT WILL BE MADE REGARDING POTENTIAL PRODUCT PERFORMANCE ISSUES, COMPONENT INTEGRITY, OR MANUFACTURING DEFECTS. CAPA DETERMINATION: BASED ON THE AVAILABLE INFORMATION, NO FURTHER INVESTIGATION IS REQUIRED NOR CAPA PLAN IS NEEDED. THE RECORD WILL BE CLOSED AND MONITORED THROUGH TRACKING AND TRENDING (MONTHLY TRIPS AND ALERTS). SUMMARY CONCLUSION: BASED ON THE AVAILABLE INFORMATION, THE INVESTIGATION HAS BEEN PERFORMED, AND THE COMPLAINT COULD NOT BE CONFIRMED AS ANALYZED. THEREFORE, THE COMPLAINT IS CLOSED BASED ON THE EVENT DESCRIPTION AND ALL INFORMATION MADE AVAILABLE.

Description of Event or Problem · 0

REFERENCE NUMBER: (B)(4). EVENT OCCURRED IN THE UNITED STATES. IT WAS REPORTED THAT PATIENT FACED INFUSION SET LEAKAGE AT SITE ON (B)(6) 2023. THE INFUSION SET HAD BEEN IN USE FOR APPROXIMATELY FIVE DAYS. NO FURTHER INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
766484 INSET GUARD UNO EWIS BLUE 80/9 HCAP 1-PK INT FPA UNOMEDICAL A/S MMT-442AJ 6002062 05705244023079

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown